Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 341

1.

Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.

Bosch-Marcè M, Clària J, Titos E, Masferrer JL, Altuna R, Poo JL, Jiménez W, Arroyo V, Rivera F, Rodés J.

Gastroenterology. 1999 May;116(5):1167-75.

PMID:
10220509
2.

Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.

López-Parra M, Clària J, Planagumà A, Titos E, Masferrer JL, Woerner BM, Koki AT, Jiménez W, Altuna R, Arroyo V, Rivera F, Rodés J.

Br J Pharmacol. 2002 Feb;135(4):891-900.

3.

NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.

Wallace JL, McKnight W, Reuter BK, Vergnolle N.

Gastroenterology. 2000 Sep;119(3):706-14.

PMID:
10982765
4.

Prostaglandins that increase renin production in response to ACE inhibition are not derived from cyclooxygenase-1.

Cheng HF, Wang SW, Zhang MZ, McKanna JA, Breyer R, Harris RC.

Am J Physiol Regul Integr Comp Physiol. 2002 Sep;283(3):R638-46.

5.

Role of cyclooxygenase-2 in the prolonged regulation of renal function.

Roig F, Llinás MT, López R, Salazar FJ.

Hypertension. 2002 Nov;40(5):721-8.

6.

Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats.

Richter CM, Godes M, Wagner C, Maser-Gluth C, Herzfeld S, Dorn M, Priem F, Slowinski T, Bauer C, Schneider W, Neumayer HH, Kurtz A, Hocher B.

J Hypertens. 2004 Jan;22(1):191-8.

PMID:
15106811
7.

Renal effects of selective cyclooxygenase inhibition in experimental liver disease.

López-Parra M, Clària J, Planagumà A, Titos E, Masferrer JL, Woerner BM, Koki AT, Jiménez W, Arroyo V, Rivera F, Rodés J.

Adv Exp Med Biol. 2003;525:133-6. No abstract available.

PMID:
12751752
8.

Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.

Clària J, Kent JD, López-Parra M, Escolar G, Ruiz-Del-Arbol L, Ginès P, Jiménez W, Vucelic B, Arroyo V.

Hepatology. 2005 Mar;41(3):579-87.

PMID:
15723448
9.

Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake.

Rodríguez F, Llinás MT, González JD, Rivera J, Salazar FJ.

Hypertension. 2000 Aug;36(2):276-81.

11.

Effect of cyclooxygenase-2 inhibition on renal function after renal ablation.

Sanchez PL, Salgado LM, Ferreri NR, Escalante B.

Hypertension. 1999 Oct;34(4 Pt 2):848-53.

13.
14.

Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics.

Harding P, Carretero OA, Beierwaltes WH.

J Hypertens. 2000 Aug;18(8):1107-13.

PMID:
10954003
15.

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.

Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M.

Clin Pharmacol Ther. 1999 Jul;66(1):76-84.

PMID:
10430112
16.

Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.

Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ, FitzGerald GA.

J Pharmacol Exp Ther. 1999 May;289(2):735-41.

17.

Role of cyclooxygenase-2-derived metabolites and nitric oxide in regulating renal function.

Llinás MT, Rodríguez F, Moreno C, Salazar FJ.

Am J Physiol Regul Integr Comp Physiol. 2000 Nov;279(5):R1641-6.

19.

[Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].

Ortiz MC, Fortepiani LA, Martínez-Salgado C, Eleno N, Atucha NM, López-Novoa JM, García-Estañ J.

Nefrologia. 2001;21(6):556-64. Spanish.

20.

Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites.

Angeli P, Jiménez W, Arroyo V, Mackenzie HS, Zhang PL, Clària J, Rivera F, Brenner BM, Rodés J.

Hepatology. 1994 Oct;20(4 Pt 1):948-54.

PMID:
7927237
Items per page

Supplemental Content

Write to the Help Desk